Matthew L. Sherman, EVP & Chief Medical Officer: Deciphera Pharmaceuticals DCPH Sell · Filed 23/12/14

Trade details

Type: Insider sale
Amount: $42,913.04
Shares · price: 2,792 sh · $15.37 a share
Held after: 96,514 sh
Stock: Deciphera Pharmaceuticals DCPH
Person: Matthew L. ShermanEVP & Chief Medical Officer
Trade date: 23/12/13
Filed: 23/12/14
Days to filing: 1 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Deciphera Pharmaceuticals trades, last 26 weeks

What else happened in Deciphera Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/11/13~24/01/12

Matthew L. Sherman's recent trades

Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$40.8K
2,615 sh
$40.8K
Filed 24/02/20
Traded 24/02/16
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$35.2K
2,435 sh
$35.2K
Filed 24/01/18
Traded 24/01/16
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$28.4K
2,360 sh
$28.4K
Filed 23/10/31
Traded 23/10/30
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$37.3K
2,942 sh
$37.3K
Filed 23/10/04
Traded 23/10/02
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$23.8K
1,655 sh
$23.8K
Filed 23/06/21
Traded 23/06/16